The hepatocyte growth factor receptor (MET): An unconventional transducer of mitogenic and motogenic signals

Growth Factors and Cytokines in Health and Disease

Volumn 1, Issue C, 1996, Pages 465-490

  Comoglio, Paolo M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0342837167     PISSN: 18745687     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1874-5687(96)80019-X     Document Type: Article

References (142)

1. Appella E., Robinson E.A., Ullrich S.J., Stoppelli M.P., Corti A., Cassani G., and Blasi F. The receptor-binding sequence of urokinase. J. Biol. Chem. 262 (1987) 4437-4440
2. Barr J. Mammalian subtilisins: the long-sought dibasic processing endoproteases. Cell 66 (1991) 1-3
3. Bellusci S., Moens G., Gaudino G., Comoglio P.M., Nakamura T., Thiery J.P., and Jouanneau J. Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. Oncogene 9 (1994) 1091-1099
4. Bertics P.J., and Gill G.N. Self-phosphorylation enhances the protein-tyrosine kinase activity of the epidermal growth factor receptor. J. Biol. Chem. 260 (1985) 14642-14647
5. Bjorge J.D., and Kudlow J.E. Epidermal growth factor receptor synthesis is stimulated by phorbol ester and epidermal growth factor. J. Biol. Chem. 262 (1987) 6615-6622
6. Boccaccio C., Gaudino G., Gambarotta G., Galimi F., and Comoglio P.M. Hepatocyte growth factor (HGF) receptor expression is inducible and is part of the delayed early response to HGF. J. Biol. Chem. 269 (1994) 12846-12851
7. Bottaro D.P., Rubin J.S., Faletto D.L., Chan A.M.L., Kmiecick T.E., Van d.W.G.F., and Aaronson S.A. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene. Science 251 (1991) 802-804
8. Bussolino F., Di R.M.F., Ziche M., Bocchietto E., Olivero M., Naldini L., Gaudino G., Tamagnone L., Coffer A., Marchisio P.C., and Comoglio P.M. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol. 119 (1992) 629-641
9. Cantley L.C., Auger K., Carpenter C., Duckworth B., Graziani A., Kapeller R., and Soltoff S. Oncogenes and signal transduction. Cell 64 (1991) 281-302
10. Chan A.M.-L., Rubin J.S., Bottaro D.P., Hirschfield D.W., Chedid M., and Aaronson S.A. Identification of a competitive HGF antagonist encoded by an alternative transcript. Science 254 (1991) 1382-1385
11. Clark A.J.L., Ishii S., Richert N., Merlino G.T., and Pastan I. The human hematopoietic colony-stimulating factors. Proc. Natl. Acad. Sci. USA 82 (1985) 8374-8378
12. Cochet C., Kashles O., Chambaz E.M., Borello I., King C.R., and Schlessinger J. Demon-stration of epidermal growth factor-induced receptor dimerization in living cells using a chemical covalent cross-linking agent. J.Biol.Chem. 263 (1988) 3290-3295
13. Cooper C.S., Park M., Blair D.G., Tainsky M.A., Huebner K., Croce C.M., and Van d.W.G. Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 311 (1984) 29-33
14. Cooper C.S., Tempest P.R., Beckman v., Heldin C.-H., and Brooks P. Amplification and overexpression of the met gene in spontaneously transformed NIH3T3 mouse fibroblasts. EMBO 5 (1986) 2623-2628
15. Crepaldi T., Prat M., Giordano S., Medico E., and Comoglio P.M. Generation of a truncated hepatocyte growth factor receptor in the endoplasmic reticulum. J. Biol. Chem. 269 (1994) 1750-1755
16. Crepaldi T., Pollack A.L., Prat M., Zborek A., Mostov K., and Comoglio P.M. Targeting of the SF/HGF receptor to the basolateral domain of polarized epithelial cells. J. Cell Biol. 125 (1994) 313-320
17. Dean M., Park M., and Van d.W.G.F. Characterization of the rearranged TPR-MET oncogene breakpoint. Mol. Cell. Biol. 7 (1987) 921-924
18. Di R.M.F., Narsimhan R.P., Olivero M., Bretti S., Giordano S., Medico E., Gaglia P., Zara P., and Comoglio P.M. Expression of the MET/HGF receptor in normal and neoplastic human tissues. Oncogene 6 (1991) 1997-2003
19. Di R.M.F., Olivero M., Ferro S., Prat M., Bongarzone I., Pilotti S., Pierotti M.A., and Comogiio P.M. Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. Oncogene 7 (1992) 2549-2553
20. Di R.M.F., Olivero M., Bertolotto A., Crepaldi T., Schiffer D., Pagni C.A., and Comoglio P.M. Selective expression of the MET/HGF receptor in human central nervous system microglia. Oncogene 8 (1993) 219-222
21. Di Renzo M.F., Olivero M., Katsaros D., Crepaldi T., Gaglia P., Zola P., Sismondi P., and Comoglio P.M. Overexpression of the MET/HGF receptor in ovarian cancer. Int. J. Cancer 58 (1994) 658-662
22. Di Renzo M.F., Poulsom R., Olivero M., Comoglio P.M., and Lemoine N.R. Expression of the MET/hepatocyte growth factor receptor in human pancreatic cancer. Cancer Res. 55 (1995) 1129-1138
23. Di Renzo M.F., Olivero M., Giacomini A., Porte H., Chastre E., Mirossay L., Nordlinger B., Bretti S., Bottardi S., Giordano S., Plebani M., Gespach C., and Comoglio P.M. Overexpres-sion and amplification of the MET/HGF receptor gene during the progression of colorectal cancer. Clin. Cancer Res. 1 (1995) 147-154
24. Downword J., Yarden Y., Mayes E., Scrace G., Totty N., Stockwell P., Ullrich A., Schlessinger J., and Waterfield M.D. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature 307 (1984) 521-527
25. Earp H.S., Austin K.S., Blaisdell J., Rubin R.A., Nelson K.G., Lee L.W., and Grisham J.W. Epidermal growth factor (EGF) stimulates EGF receptor synthesis. J. Biol. Chem. 261 (1986) 4777-4780
26. lck. Nature 362 (1993) 87-91
27. Fantl W.J., Escobedo J.A., Martin G.A., Turck C.W., Rosario M., McCormick F., and Williams L.T. Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways. Cell 69 (1992) 413-423
28. Felder S., Zhou M., Hu P., Ureña J., Ullrich A., Chaudhuri M., White M., Shoelson S.E., and Schlessinger J. SH2 domains exhibit high-affinity binding to tyrosine-phosphorylated peptides yet also exhibit rapid dissociation and exchange. Mol. Cell. Biol. 13 (1993) 1449-1455
29. Ferracini R., Longati P., Naldini L., Vigna E., and Comoglio P.M. Identification of the major phosphorylation site of the MET/hepatocyte growth factor receptor tyrosine kinase. J. Biol. Chem. 266 (1991) 19558-19564
30. Ferracini R., Di R.M.F., Scotlandi K., Baldini N., Olivero M., Lollini P., Cremona O., Campanacci M., and Comoglio P.M. The MET/HGF receptor is overexpressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit. Oncogene 10 (1995) 739-749
31. Fukuyama R., Ichijoh Y., Minoshima S., Kitamura N., and Shimuzu N. Regional localization of the hepatocyte growth factor (HGF) gene to human chromosome 7 band q21.1. Genomics 11 (1991) 410-415
32. Galimi F., Brizzi M.F., and Comoglio P.M. The hepatocyte growth factor and its receptor. Stem Cells 11 (1993) 22-30
33. Galimi F., Bagnara G.P., Bonsi L., Cottone E., Follenzi A., and Simeone A. Hepatocyte growth factor induces proliferation and differentation of multipotent and erythroid hemopoietic progeni-tors. J. Cell Biol. 127 6 (1994) 1743-1754
34. Gambarotta G., Pistoi S., Giordano S., Comoglio P.M., and Santoro C. Structure and inducible regulation of the human met promoter stem cells 11 (1994) 22-30
35. Gambarotta G., Pistoi S., Giordano S., Comoglio P.M., and Santoro C. J. Biol. Chem. 269 (1993) 12852-12857
36. Gandino L., Di R.M.F., Giordano S., Bussolino F., and Comoglio P.M. Protein kinase-C activation inhibits tyrosine phosphorylation of the c-MET protein. Oncogene 5 (1990) 721-725
37. Gandino L., Munaron L., Naldini L., Ferracini R., Magni M., and Comoglio P.M. Intracellular calcium regulates the tyrosine kinase receptor encoded by the MET oncogene. J. Biol. Chem. 266 (1991) 16098-16104
38. 985 negatively regulates the hepatocyte growth factor receptor kinase. J. Biol. Chem. 269 (1994) 1815-1820
39. Gaudino G., Follenzi A., Naldini L., Collesi C., Santoro M., Gallo K.A., Godowski P.J., and Comoglio P.M. Ron is a heterodimeric tyrosine kinase receptor activated by the HGF homolog MSP. EMBO J. 13 (1994) 3524-3532
40. Gherardi G., Gray J., Stoker M., Perryman M., and Furlong R. Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interaction and movement. Proc. Natl. Acad. Sci. USA 86 (1989) 5844-5848
41. Giordano S., Ponzetto C., Di R.M.F., Cooper C.S., and Comoglio P.M. Tyrosine kinase receptor indistinguishable from the c-MET protein. Nature 339 (1989) 155-156
42. Giordano S., Di R.M.F., Narsimhan R.P., Cooper C.S., Rosa C., and Comoglio P.M. Biosynthesis of the protein encoded by the c-MET proto-oncogene. Oncogene 4 (1989) 1383-1388
43. Giordano S., Zhen Z., Medico E., Gaudino G., Galimi F., and Comoglio P.M. Transfer of motogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of human MET protooncogene. Proc. Natl. Acad. Sci. USA 90 (1993) 64
44. Gohda E., Tsubouchi H., Nakayama H., Hirono S., Sakiyama O., Takahashi K., Miyazaki H., Hashimoto S., and Daikuhara Y. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with hepatic failure. J. Clin. Invest. 81 (1988) 414-419
45. Gonzatti-Haces M., Seth A., Park M., Copeland T., Oroszlan S., and Van d.W.G.F. Characterization of the TPR-MET oncogene p65and the MET proto-oncogene pi40 protein tyrosine kinases. Proc. Natl. Acad. Sci. USA 85 (1988) 21-25
46. Grant D.S., Kleinmann H.K., Goldberg I.D., Bhargava M., Nickoloff B.J., Kinsella J.K., Polverini P.J., and Rosen E.M. Scatter factor induces blood vessel formation in vivo. Proc. Natl. Acad. Sci. USA 90 (1993) 1937-1941
47. Graziani A., Gramaglia D., Cantley L.C., and Comoglio P.M. The tyrosine phosphorylated hepatocyte growth factor/scatter factor receptor associates with phosphatidylinositol 3-kinase. J. Biol. Chem. 266 (1991) 22087-22090
48. Graziani A., Gramaglia D., dalla Z.P., and Comoglio P.M. Hepatocyte growth factor/scatter factor stimulates the ras-guanine nucleotide exchanger. J. Biol. Chem. 268 (1993) 9165-9168
49. Greenfield C., Hils I., Waterfield M.D., Federwisch W., Wollmer A., Blundell T.L., and McDonald N. Epidermal growth factor binding induces a conformational change in the external domain of its receptor. EMBO J. 8 (1989) 4115-4124
50. Halaban R., Rubin J., Funasaka Y., Cobb C., Boulton T., Faletto D., Rosen E., Chan A., Yoko K., White W., Cook C., and Moellmann G. Met and HGF/SF signal transduction in normal melanocytes and melanoma cells. Oncogene 7 (1992) 2195-2206
51. Hammacher A., Mellstrom K., Heldin C.-H., and Westermark B. Isoform-specific induction of actin reorganization by platelet-derived growth factor suggests that the functionally active receptor is a dimer. EMBO J. 8 (1989) 2489-2495
52. Heldin C.H., Ernlund A., Rorsman C., and Ronnstrand L. Dimerization of B-type platelet-de-rived growth factor receptors is closely associated with receptor kinase activation. J. Biol. Chem. 264 (1989) 8905-8912
53. Han S., Stuart L.A., and Friezner-Degen S.J. Characterization of the DNF15S2 locus on human chromosome 3: Identification of a gene coding for four kringle domains with homology to hepatocyte growth factor. Biochemistry 30 (1991) 9768-9780
54. Hanks S.K., Quinn A.M., and Hunter T. The protein kinase family: Conserved features and deduced phylogeny of the catalytic domains. Science 241 (1988) 42-52
55. Hartmann G., Naldini L., Weidner M., Sachs M., Vigna E., Comoglio P., and Birchmeier W. A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-MET receptor and induces cell dissociation but not mitogenesis. Proc. Natl. Acad. Sci. USA 89 (1992) 11574-11578
56. Higashio K., Shima N., Goto M., Itagaki Y., Nagao M., Yasuda H., and Morinaga T. Identity of a tumor cytotoxic factor from human fibroblasts and hepatocyte growth factor. Biochem. Biophys. Res. Comm. 170 1 (1990) 397-404
57. Huff J.I., Jelinek A.M., Borgman C.A., Lansing T.J., and Parsons J.T. The proto-oncogene c-sea encodes a transmembrane protein-tyrosine kinase related to the MET/hepatocyte growth factor/scatter factor receptor. Proc. Natl. Acad. Sci. USA 90 (1993) 6140-6144
58. Imagawa M., Chiu R., and Karin M. Transcription factor AP-2 mediates induction by two different signal transduction pathways: Protein kinase C and cAMP. Cell 51 (1987) 251-260
59. Ito T., Hayashi N., Horimoto M., Sasaki Y., Tanaka Y., Kaneko A., Fusamoto H., and Kamada T. Expression of the c-met/hepatocyte growth factor receptor gene during rat liver regen-eration induced by carbon tetrachloride. Biochem. Biophys. Res. Comm. 190 (1993) 870-874
60. Kan M., Zhang G.H., Zarnegar R., Michalopoulos G., Myoken Y., Mckeehan W.L., and Stevens J.L. Hepatocyte growth factor/hepatopoietin A stimulates the growth of rat kidney proximal tubule epithelial cells (RPTE), rat nonparenchymal liver cells, human melanoma cells, mouse keratinocytes and stimulates anchorage-independent growth of SV40-transformed RPTE. Bio-chem. Biophys. Res. Commun. 174 (1991) 331-337
61. Kennelly P.J., and Krebs E.G. Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases. J. Biol. Chem. 266 (1991) 15555-15558
62. Khazaie K., Dull T.J., Graf T., Schlessinger J., Ullrich A., Beug H., and Vennstrom B. Truncation of the human EGF receptor leads to differential transforming potentials in primary avian fibroblasts and erythroblasts. EMBO J. 7 (1988) 3061-3071
63. Kim H.K., Kim J.W., Zilberstein A., Margolis B., Kim J.G., Schlessinger J., and Rhee S.G. PDGF stimulation of inositol phospholipid hydrolysis requires PLCγ1 phosphorylation on tyrosine residues 783 and 1254. Cell 65 (1991) 435-441
64. Kmiecik T.E., Keller I.R., Rosen E., and Van d.W.G.F. Hepatocyte growth factor is a synergic factor for the growth of hematopoietic progenitor cells. Blood 16 (1992) 2454-2457
65. Kobayashi T., Honke K., Miyazaki T., Matsumoto K., Nakamura K., Ishizuka I., and Matika A. Hepatocyte growth factor specifically binds to sulfoglycololipids. J. Biol. Chem. 269 (1994) 9817-9821
66. Koch C.A., Anderson D., Moran M.F., Ellis C., and Pawson T. SH2 and SH3 domains: Elements that control interactions of cytoplasmic signaling proteins. Science 252 (1991) 668-674
67. Levy J.R., and Hug V. Regulation of insulin receptor gene expression. J. Biol. Chem. 267 (1992) 25289-25295
68. 4 administration. Hepatology 13 (1991) 743-750
69. Liu C., Park M., and Tsao M.-S. Overexpression of c-MET proto-oncogene but not epidermal growth factor receptor or c-erbB-2 in primary colorectal carcinomas. Oncogene 7 (1992) 181-185
70. Lokker N.A., Mark M.R., Luis E.A., Bannet G.L., Robbins K.A., Baker J.B., and Godowski P.J. Structure-function analysis of hepatocyte growth factor: Identification of variants that lack mitogenic activity yet retain high affinity receptor binding. EMBO J. 11 (1992) 2503-2510
71. Lokker N., and Godowski P.J. Generation and characterization of a competitive antagonist of human hepatocyte growth factor, NGF/NK1. J. Biol. Chem. 268 (1993) 17145-17150
72. Longati P., Bardelli A., Ponzetto C., Naldini L., and Comoglio P.M. Tyrosines 1234-1235 are critical for activation of the tyrosine kinase encoded by the MET proto-oncogene (HGF receptor). Oncogene 9 (1994) 49-57
73. Mark M.R., Lokker N.A., Zioncheck T.F., Luis E.A., and Godowski P.J. Expression and characterization of hepatocyte growth factor receptor-IgG fusion proteins. J. Biol. Chem. 267 (1992) 26166-26171
74. Martin D.I., Tsai S.F., and Orkin S.H. Increased γ-globin expression in a nondeletion HPFH mediated by an erythroid-specifïc DNA-binding factor. Nature 338 (1989) 435-438
75. Matsumoto K., Hashimoto K., Yoshikawa K., and Nakamura T. Marked stimulation of growth and motility of human keratinocytes by hepatocyte growth factor. Exp. Cell Res. 196 (1991) 114-120
76. in press. Medico E., Mongiovi' A.M., Follenzi A., Huff J., Jelinex M.A., Gaudino G., Parsons J.T., and Comoglio P.M. The met-related tyrosine kinase receptors ron and sea control motility, growth and morphogenesis in liver progenitor cells in vitro. Mol. Cell. Biol. (1996)
77. Michalopoulos G.K. Liver regeneration: Molecular mechanisms of growth control. FASEB J. 4 (1990) 176-187
78. Mitchell P.J., and Cooper C. Nucleotide sequence analysis of human tpr cDNA clones. Oncogene 7 (1992) 383-388
79. Mitchell P.J., and Cooper C. The human tpr gene encodes a protein of 2094 amino acids that has extensive coiled-coil regions and an acidic C-terminal domain. Oncogene 7 (1992) 2329-2333
80. Miyazawa K., Tsubouchi H., Naka D., Takahashi K., Okigaki M., Arakaki N., Nakayama H., Hirono S., Sakiyama O., Takahashi K., Gohda E., Daikuhara Y., and Kitamura N. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem. Biophys. Res. Commun. 163 (1989) 967-973
81. Miyazawa K., Kitamura A., Naka D., and Kitamura N. An alternatively processed mRNA generated from human hepatocyte growth factor gene. Eur. J. Biochem. 197 (1991) 15-22
82. Miyazawa K., Shimomura T., Kitamura A., Kondo J., Morimoto Y., and Kitamura N. Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor. J. Biol. Chem. 268 (1993) 10024-10028
83. Mondino A., Giordano S., and Comoglio P.M. Defective posttranslational processing activates the tyrosine kinase encoded by the MET proto-oncogene (hepatocyte growth factor receptor). Mol. Cell. Biol. 11 (1991) 6084-6092
84. Montesano R., Matsumoto K., Nakamura T., and Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 67 (1991) 901-908
85. Nakamura T., Teramoto H., and lchihara A. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc. Natl. Acad. Sci. USA 86 (1986) 6489-6493
86. Nakamura T., Nishizawa T., Hagiya M., Seki T., Shimonishi M., Sugimura A., Tashiro K., and Shimizu S. Molecular cloning and expression of human hepatocyte growth factor. Nature 342 (1989) 440-443
87. Naldini L., Vigna E., Ferracini R., Longati P., Gandino L., Prat M., and Comoglio P.M. The tyrosine kinase encoded by the MET proto-oncogene is activated by autophosphorylation. Mol. Cell. Biol. 11 (1991) 1793-1803
88. Naldini L., Vigna E., Narshiman R.P., Gaudino G., Zarnegar R., Michalopoulos G., and Comoglio P.M. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. Oncogene 6 (1991) 501-504
89. Naldini L., Weidner K.M., Vigna E., Gaudino G., Bardelli A., Ponzetto C., Narsimhan R.P., Hartmann G., Zarnegar R., Michalopoulos G.K., Birchmeier W., and Comoglio P.M. Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBOJ. 10 (1991) 2867-2878
90. Naldini L., Tamagnone L., Vigna E., Sachs M., Hartmann G., Birchmeier W., Daikuhara Y., Tsubouchi H., Blasi F., and Comoglio P.M. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J. 11 (1992) 4825-4833
91. Naldini L., Vigna E., Bardelli A., Follenzi A., Galimi F., and Comoglio P.M. Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction. J. Biol. Chem. 217 (2 (1995) 603-611
92. Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334 (1988) 661-665
93. Noji S., Tashiro K., Koyama E., Nohno T., Ohyama K., Taniguchi S., and Nakamura T. Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization. Biochem. Biophys. Res. Comm. 173 (1990) 42-47
94. Panayotou G., Gish G., End P., Truong O., Gout I., Dhand R., Fry M.J., Hiles I., Pawson T., and Waterfield M.D. Interactions between SH2 domains and tyrosine-phosphorylated platelet-derived growth factor β receptor sequences: analysis of kinetic parameters by a novel biosensor-based approach. Mol. Cell. Biol. 13 (1993) 3567-3576
95. Park M., Dean M., Cooper C.S., Schmidt M., O'Brien S.J., Blair D.G., and Van d.W.G.F. Mechanism of MET oncogene activation. Cell 45 (1986) 895-904
96. Pawson T., and Schlessinger J. SH2 and SH3 domains. Curr. Biol. 3 (1993) 434-442
97. Pawson T. Protein modules and signaling networks. Nature 373 (1995) 573-576
98. Pelech S.L., and Sanghera J.S. MAP kinases: charting the regulatory pathways. Science 257 (1992) 1355-1356
99. Pendergast A.M., Quilliam L.A., Cripe L.D., Bassing C.H., Dai Z., Li N., Batzer A., Rabun K.M., Der C., Schlessinger J., and Gishizky M.L. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the Grb-2 adaptor protein. Cell 75 (1993) 175-185
100. Ponzetto C., Giordano S., Peverali F., Delia V.G., Abate M., Vaula G., and Comoglio P.M. )c-MET is amplified but not mutated in a cell line with an activated MET tyrosine kinase. Oncogene 6 (1991) 553-559
101. Ponzetto C., Bardelli A., Maina F., Longati P., Panayotou G., Dhand R., Waterfield M.D., and Comoglio P.M. A novel recognition motif for phosphatidylinositol 3-kinase binding mediates its association with the hepatocyte growth factor/scatter factor receptor. Mol. Cell. Biol. 13 (1993) 4600-4608
102. Ponzetto C., Bardelli A., Zhen Z., Maina F., dalla Z.P., Giordano S., Graziani A., Panayotou G., and Comoglio P.M. A multifunctional docking site mediates signaling and transfor-mation by the hepatocyte growth factor/scatter factor receptor family. Cell 77 (1994) 261-271
103. Prat M.P., Narsimhan R.P., Crepaldi T., Nicotra M.R., Natali P.G., and Comoglio P.M. The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, in epithelial cells and in solid tumors. Int. J. Cancer 49 (1991) 323-328
104. Qiu F., Ray P., Brown K., Barker E., Jhanwar S., Ruddle F.H., and Besmer P. Primary structure of c-kit: Relationship with the CSF-1/PDGF receptor kinases family oncogenic activation of v-kit involves deletion of extracellular domain and C terminus. EMBO. J. 7 (1988) 1003-1011
105. Rodriguez G.A., and Park M. Mol. Cell. Biol. 13 (1993) 6711-6722
106. Rong S., Bodescot M., Blair D., Dunn J., Nakamura T., Mizuno K., Park M., Chan A., Aaronson S., and Van d.W.G.F. Tumorigenicity of the MET proto-oncogene and the gene for hepatocyte growth factor. Mol. Cell. Biol. 12 11 (1992) 5152-5158
107. Rong S., Bodescot M., Blair D., Dunn J., Nakamura T., Mizuno K., Park M., Chan A., Aaronson S., and Van d.W.G.F. Mol. Cell. Biol 12 (1993) 5152-5158
108. Rong S., Segal S., Anver M., Resau J.H., and Van d.W.G.F. Invasiveness and metastasis of NIH 3T3 cells induced by MET hepatocyte growth factor/scatter factor autocrine stimulation. Proc. Natl. Acad. Sci. USA 91 (1994) 4731-4745
109. Ronsm C., Muscatelli F., Mattei M.G., and Breathnach R. A novel putative receptor protein tyrosine kinase of the MET family. Oncogene 8 (1993) 1195-1202
110. Rubin J.S., Chan A.M.L., Bottaro D.P., Burgess W.H., Taylor W.G., Cech A.C., Hirschfield D.W., Wong J., Miki T., Finch P.W., and Aaronson S.A. Proc. Natl. Acad. Sci. USA 88 (1991) 415-419
111. Rotm D., Margolis B., Mohammadi M., Daly R.J., Daum G., Li N., Fischer E.H., Burgess W.H., Ullrich A., and Schlessinger J. SH2 domains prevent tyrosine dephosphorylation of the EGF receptor: Identification of tyr992 as the high-affinity binding site for SH2 domains of phospholipase Cy. EMBO J. 11 (1992) 559-567
112. Ruoslahti E., and Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell 64 (1991) 867-869
113. Saccone S., Narsimhan R.P., Gaudino G., Dalpra' L., Comoglio P.M., and Delia V.G. Regional mapping of the human hepatocyte growth factor-scatter factor gene to chromosome 7q21.1. Genomics 13 (1992) 912-914
114. Santos O.F.P., Barros E.J.G., Yang X.-M., Matsumoto K., Nakamura T., Park M., and Nigam S.K. Dev. Biol. 163 (1994) 525-529
115. Schmidt C., Bladt F., Goedecke W., Brinkmann V., Zschiesche W., Sharpe M., Gherardi E., and Birchmeier C. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 373 (1995) 699-702
116. Seifert R.A., Hart C.E., and Philips P.E. Two different subunits associate to create isoform-specific platelet-derived growth factor. J. Biol. Chem. 264 (1989) 8771-8778
117. Shimomura T., Kondo J., Ochiai M., Naka D., Miyazawa K., Morimoto Y., and Kitamura N. Activation of the zymogen of hepatocyte growth factor activator by thrombin. J. Biol. Chem. 268 (1993) 22927-22932
118. Shoelson S.E., White M.F., and Kahn C.R. Tryptic activation of the insulin receptor. J. Biol. Chem. 10 (1988) 4852-4860
119. v-src abolishes kinase activity, transformation and tumorigenicity. Mol. Cell. Biol. 5 (1985) 1772-1779
120. Sonnenberg E., Meyer D., Weidner K.M., and Birchmeier C. Scatter factor/hepatocyte growth factor and its receptor, the c-MET tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J. Cell Biol. 123 (1993) 223-235
121. Sonnenberg E., Weidner K.M., and Birchmeier C. In: Goldberg I.D., and Rosen E.M. (Eds). Hepatocyte Growth Factor-Scatter Factor and the c-Met Receptor (1993), Birkhaüser Verlag, Basel 382-394
122. Songyang Z., Shoelson S.E., Chaudhuri M., Gish G., Pawson T., Haser W.G., King F., Roberts T., Ratnofsky S., Lechleider R.J., Neel B.G., Birge R.B., Fajardo J.E., Chou M.M., Hanafusa H., Schaffhausen B., and Cantley L.C. SH2 domains recognize specific phosphopeptide sequences. Cell 72 (1993) 1-20
123. Stoker M., Gherardi E., Perryman M., and Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327 (1987) 239-242
124. Tajima H., Matsumoto K., and Nakamura T. Hepatocyte growth factor has potent antiprolifera-tive activity in various tumour cells. FEBS 291 (1991) 229-232
125. Tempest P.R., Reeves B.R., Spurr N.K., Ranee A.J., Chan M.-L., and Brooks P. Activation of the MET oncogene in the human mnng-hos cell line involves a chromosomal rearrangement. Carcinogenesis 7 (1986) 2051-2057
126. Tornqvist H.E., Pierce M.W., Frackleton A.R., Nemenoff R.A., and Avruch J. Identification of insulin receptor tyrosine residues autophosphorylated in vitro. J. Biol. Chem. 262 (1987) 10212-10219
127. Tornqvist H.E., and Avruch J. Relationship of site-specific β subunit tyrosine autophosphoryla-tion to insulin activation of the insulin receptor (tyrosine) protein kinase activity. J. Biol. Chem. 263 (1988) 4593-4601
128. Villa-Moruzzi E., Lapi S., Prat M., Gaudino G., and Comoglio P.M. A protein tyrosine phosphatase activity associated with the hepatocyte growth factor/scatter factor receptor. J. Biol. Chem. 268 (1993) 18176-18180
129. Waksman G., Kominos D., Robertson S.R., Pant N., Baltimore D., Birge R.B., Cowburn D., Hanafusa H., Mayer B.J., Overduin M., Resh M.D., Rios C.B., Silverman L., and Kuriyan J. Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. Nature 358 (1992) 646-653
130. Waksman G., Shoelson S., Pant N., Cowburn D., and Kuriyan J. Binding of a high-affinity phosphotyrosyl peptide in the sre SH2 domain: Crystal structures of the complexed and peptide-free forms. Cell 72 (1993) 77-790
131. Weber W., Bertics P.J., and Gill G.N. Immunoaffinity purification of the epidermal growth factor receptor. Stoichiometry of binding and kinetics of self-phosphorylation. J. Biol. Chem. 259 (1984) 14631-14636
132. Weidner K.M., Behrens J., Vandekerckove J., and Birchmeier W. Scatter factor: Molecular characteristics and effect on the invasiveness of epithelial cells. J. Cell Biol. 111 (1990) 2097-2108
133. Weidner K.M., Arakaki N., Vandekerckove J., Weingart S., Hartmann G., Rieder H., Fonatsch C., Tsubouchi H., Hishida T., Daikuhara Y., and Birchmeier W. Evidence for the identity of human scatter factor and hepatocyte growth factor. Proc. Natl. Acad. Sci. USA 88 (1991) 7001-7005
134. Xin J.H., Cowie A., Lachance P., and Hassel J.A. Molecular cloning and characterization of PEA3, a new member of the ETS oncogene family that is differentially expressed in mouse embryonic cells. Genes Dev. 6 (1992) 481-496
135. Yarden Y., and Schlessinger J. Self-phosphorylation of epidermal growth factor receptor: Evidence for a model of intermolecular allosteric activation. Biochemistry 26 (1987) 1434-1442
136. Yarden Y., and Schlessinger J. EGF induces rapid, reversible aggregation of the purified epidermal growth factor receptor. Biochemistry 26 (1987) 1443-1451
137. Yoshihiko U., Minowa O., Mori C., Shiota K., Kuno J., Noda T., and Kitamura N. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 373 (1995) 702-705
138. Yoshimura T., Yuhki N., Wang M.-H., Skeel A., and Leonard E.J. Cloning, sequencing, and expression of human macrophage stimulating protein (MSP, MST1) confirms MSP as a family of kringle proteins and locates the MSP gene on chromosome 3. J. Biol. Chem. 268 (1993) 15461-15468
139. Zarnegar R., and Michalopoulos G. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes. Cancer Res. 49 (1989) 3314-3320
140. Zarnegar R., Muga S., Rahija R., and Michalopoulos G. Tissue distribution of hepatoprotein-A: A heparin-binding polypeptide growth factor for hepatocytes. Proc. Natl. Acad. Sci. USA 87 (1990) 1252-1256
141. Zarnegar R., DeFrances M.C., Kost D., Lindroos P., and Michalopoulos G.K. Expression of hepatocyte growth factor mRNA in regenerating rat liver after partial hepatectomy. Biochem. Biophys. Res. Commun. 177 (1991) 559-565
142. Zhen Z., Giordano S., Longati P., Medico E., Campiglio M., and Comoglio P.M. Structural and functional domains critical for constitutive activation of the HGF receptor (MET). Oncogene 9 (1994) 1691-1697